Drug Pipeline Progress: Positive clinical trial results for Mankai's drug candidates tend to drive the stock price up, while negative results or trial failures can cause it to fall.

Regulatory Approvals: FDA approvals or rejections for their drugs are major price catalysts. Approval usually leads to significant gains, rejection to substantial losses.

Market Sentiment: Overall investor optimism or pessimism about the biotechnology sector and the general stock market influences MNKA.US, even without company-specific news.

Competitor Activities: Developments by competitors, such as successful clinical trials or drug approvals, can affect investor perception and MNKA.US's market position, impacting its price.

Financial Performance: Revenue, earnings, and cash flow reports are analyzed by investors. Strong financial performance usually supports a higher stock price.

Partnerships and Acquisitions: Collaborations with other pharmaceutical companies or potential acquisition offers can significantly impact investor sentiment and the stock price.

Debt Levels and Cash Position: The company's financial stability is evaluated based on its debt and cash reserves. High debt and low cash can negatively affect the stock price.